Medical - Healthcare Information Services
Build Your Comparison
Side-by-side financial analysisStock Comparison
FORA vs INFU vs BRT vs HCSG vs KO
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
REIT - Residential
Medical - Care Facilities
Beverages - Non-Alcoholic
FORA vs INFU vs BRT vs HCSG vs KO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Instruments & Supplies | REIT - Residential | Medical - Care Facilities | Beverages - Non-Alcoholic |
| Market Cap | $68M | $190M | $280M | $1.64B | $341.71B |
| Revenue (TTM) | $30M | $142M | $98M | $1.84B | $49.28B |
| Net Income (TTM) | $-5M | $8M | $-12M | $59M | $13.70B |
| Gross Margin | 46.8% | 56.7% | 41.5% | 13.3% | 61.7% |
| Operating Margin | -13.4% | 9.1% | 12.4% | 3.0% | 29.3% |
| Forward P/E | — | 22.2x | — | 21.2x | 24.3x |
| Total Debt | $12K | $3M | $508M | $25M | $45.49B |
| Cash & Equiv. | $13M | $3M | $25M | $161M | $10.27B |
FORA vs INFU vs BRT vs HCSG vs KO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Forian Inc. (FORA) | 100 | 21.5 | -78.5% |
| InfuSystem Holdings… (INFU) | 100 | 49.8 | -50.2% |
| BRT Apartments Corp. (BRT) | 100 | 85.3 | -14.7% |
| Healthcare Services… (HCSG) | 100 | 76.4 | -23.6% |
| The Coca-Cola Compa… (KO) | 100 | 149.4 | +49.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FORA vs INFU vs BRT vs HCSG vs KO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FORA has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
- Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
- 50.1% revenue growth vs BRT's 1.5%
- Beta 0.21 vs INFU's 1.22, lower leverage
Among these 5 stocks, INFU doesn't own a clear edge in any measured category.
BRT is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.45, yield 7.0%
- 221.6% 10Y total return vs INFU's 240.1%
- Beta 0.45, yield 7.0%, current ratio 0.86x
- 7.0% yield, vs KO's 2.6%, (3 stocks pay no dividend)
HCSG is the #2 pick in this set and the best alternative if value and momentum is your priority.
- Lower P/E (21.2x vs 24.3x)
- +58.9% vs BRT's -0.2%
KO ranks third and is worth considering specifically for quality and efficiency.
- 27.8% margin vs FORA's -17.0%
- 13.1% ROA vs FORA's -11.8%, ROIC 15.8% vs -7.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 50.1% revenue growth vs BRT's 1.5% | |
| Value | Lower P/E (21.2x vs 24.3x) | |
| Quality / Margins | 27.8% margin vs FORA's -17.0% | |
| Stability / Safety | Beta 0.21 vs INFU's 1.22, lower leverage | |
| Dividends | 7.0% yield, vs KO's 2.6%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +58.9% vs BRT's -0.2% | |
| Efficiency (ROA) | 13.1% ROA vs FORA's -11.8%, ROIC 15.8% vs -7.5% |
FORA vs INFU vs BRT vs HCSG vs KO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FORA vs INFU vs BRT vs HCSG vs KO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
KO leads in 3 of 6 categories
HCSG leads 1 • FORA leads 0 • INFU leads 0 • BRT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
KO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
KO is the larger business by revenue, generating $49.3B annually — 1640.0x FORA's $30M. KO is the more profitable business, keeping 27.8% of every revenue dollar as net income compared to FORA's -17.0%. On growth, KO holds the edge at +12.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $30M | $142M | $98M | $1.8B | $49.3B |
| EBITDAEarnings before interest/tax | -$4M | $26M | $39M | $72M | $15.5B |
| Net IncomeAfter-tax profit | -$5M | $8M | -$12M | $59M | $13.7B |
| Free Cash FlowCash after capex | $2M | $20M | $12M | $139M | $12.6B |
| Gross MarginGross profit ÷ Revenue | +46.8% | +56.7% | +41.5% | +13.3% | +61.7% |
| Operating MarginEBIT ÷ Revenue | -13.4% | +9.1% | +12.4% | +3.0% | +29.3% |
| Net MarginNet income ÷ Revenue | -17.0% | +5.6% | -12.5% | +3.2% | +27.8% |
| FCF MarginFCF ÷ Revenue | +7.8% | +14.3% | +12.7% | +7.6% | +25.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.9% | -3.0% | +4.2% | +6.6% | +12.1% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.0% | +5.9% | -16.7% | +175.0% | +18.2% |
Valuation Metrics
Evenly matched — INFU and HCSG each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 26.1x trailing earnings, KO trades at a 14% valuation discount to INFU's 30.4x P/E. On an enterprise value basis, INFU's 7.5x EV/EBITDA is more attractive than KO's 25.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $68M | $190M | $280M | $1.6B | $341.7B |
| Enterprise ValueMkt cap + debt − cash | $55M | $190M | $763M | $1.5B | $376.9B |
| Trailing P/EPrice ÷ TTM EPS | -23.48x | 30.39x | -22.56x | 28.32x | 26.12x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.16x | — | 21.19x | 24.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 2.34x |
| EV / EBITDAEnterprise value multiple | — | 7.55x | 20.41x | 23.07x | 25.45x |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 1.33x | 2.89x | 0.89x | 7.13x |
| Price / BookPrice ÷ Book value/share | 2.27x | 3.47x | 1.51x | 3.28x | 9.99x |
| Price / FCFMarket cap ÷ FCF | 23.49x | 7.97x | 42.18x | 11.81x | 64.52x |
Profitability & Efficiency
KO leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
KO delivers a 41.1% return on equity — every $100 of shareholder capital generates $41 in annual profit, vs $-17 for FORA. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRT's 2.87x. On the Piotroski fundamental quality scale (0–9), INFU scores 8/9 vs BRT's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.2% | +14.0% | -6.8% | +11.8% | +41.1% |
| ROA (TTM)Return on assets | -11.8% | +7.9% | -1.7% | +7.3% | +13.1% |
| ROICReturn on invested capital | -7.5% | +12.5% | +1.3% | +9.0% | +15.8% |
| ROCEReturn on capital employed | -8.2% | +14.3% | +1.6% | +7.7% | +17.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 8 | 3 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.00x | 0.06x | 2.87x | 0.05x | 1.33x |
| Net DebtTotal debt minus cash | -$13M | $241,000 | $483M | -$136M | $35.2B |
| Cash & Equiv.Liquid assets | $13M | $3M | $25M | $161M | $10.3B |
| Total DebtShort + long-term debt | $12,137 | $3M | $508M | $25M | $45.5B |
| Interest CoverageEBIT ÷ Interest expense | -48.78x | 15.54x | 0.51x | 33.02x | 10.70x |
Total Returns (Dividends Reinvested)
HCSG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KO five years ago would be worth $16,528 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, HCSG leads with a +58.9% total return vs BRT's -0.2%. The 3-year compound annual growth rate (CAGR) favors HCSG at 17.3% vs BRT's -3.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.4% | +12.3% | +4.7% | +32.2% | +16.4% |
| 1-Year ReturnPast 12 months | +2.4% | +52.2% | -0.2% | +58.9% | +17.7% |
| 3-Year ReturnCumulative with dividends | -7.3% | -7.6% | -11.2% | +61.4% | +39.3% |
| 5-Year ReturnCumulative with dividends | -82.7% | -50.2% | +13.1% | -23.2% | +65.3% |
| 10-Year ReturnCumulative with dividends | -90.5% | +240.1% | +221.6% | -29.3% | +115.0% |
| CAGR (3Y)Annualised 3-year return | -2.5% | -2.6% | -3.9% | +17.3% | +11.7% |
Risk & Volatility
KO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
KO is the less volatile stock with a -0.23 beta — it tends to amplify market swings less than INFU's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KO currently trades 94.5% from its 52-week high vs FORA's 80.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 1.22x | 0.45x | 1.08x | -0.23x |
| 52-Week HighHighest price in past year | $2.71 | $11.04 | $16.69 | $24.39 | $84.04 |
| 52-Week LowLowest price in past year | $1.64 | $5.38 | $13.18 | $12.66 | $65.35 |
| % of 52W HighCurrent price vs 52-week peak | +80.1% | +85.3% | +89.2% | +94.1% | +94.5% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 41.5 | 52.6 | 63.6 | 49.2 |
| Avg Volume (50D)Average daily shares traded | 40K | 172K | 32K | 638K | 13.6M |
Analyst Outlook
Evenly matched — BRT and KO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: INFU as "Buy", BRT as "Buy", HCSG as "Hold", KO as "Buy". Consensus price targets imply 59.2% upside for INFU (target: $15) vs 6.8% for HCSG (target: $25). For income investors, BRT offers the higher dividend yield at 7.05% vs KO's 2.56%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | $15.00 | $21.00 | $24.50 | $86.13 |
| # AnalystsCovering analysts | — | 3 | 5 | 15 | 48 |
| Dividend YieldAnnual dividend ÷ price | — | — | +7.0% | — | +2.6% |
| Dividend StreakConsecutive years of raises | — | — | 0 | 19 | 56 |
| Dividend / ShareAnnual DPS | — | — | $1.05 | — | $2.04 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +5.8% | +1.8% | +3.7% | +0.2% |
KO leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HCSG leads in 1 (Total Returns). 2 tied.
FORA vs INFU vs BRT vs HCSG vs KO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FORA or INFU or BRT or HCSG or KO a better buy right now?
For growth investors, Forian Inc.
(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus 1. 5% for BRT Apartments Corp. (BRT). The Coca-Cola Company (KO) offers the better valuation at 26. 1x trailing P/E (24. 3x forward), making it the more compelling value choice. Analysts rate InfuSystem Holdings, Inc. (INFU) a "Buy" — based on 3 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FORA or INFU or BRT or HCSG or KO?
On trailing P/E, The Coca-Cola Company (KO) is the cheapest at 26.
1x versus InfuSystem Holdings, Inc. at 30. 4x. On forward P/E, Healthcare Services Group, Inc. is actually cheaper at 21. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — FORA or INFU or BRT or HCSG or KO?
Over the past 5 years, The Coca-Cola Company (KO) delivered a total return of +65.
3%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: INFU returned +240. 1% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FORA or INFU or BRT or HCSG or KO?
By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.
23β versus InfuSystem Holdings, Inc. 's 1. 22β — meaning INFU is approximately -621% more volatile than KO relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 3% for BRT Apartments Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — FORA or INFU or BRT or HCSG or KO?
By revenue growth (latest reported year), Forian Inc.
(FORA) is pulling ahead at 50. 1% versus 1. 5% for BRT Apartments Corp. (BRT). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to -26. 9% for BRT Apartments Corp.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FORA or INFU or BRT or HCSG or KO?
The Coca-Cola Company (KO) is the more profitable company, earning 27.
3% net margin versus -12. 3% for BRT Apartments Corp. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -8. 2% for FORA. At the gross margin level — before operating expenses — KO leads at 61. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FORA or INFU or BRT or HCSG or KO more undervalued right now?
On forward earnings alone, Healthcare Services Group, Inc.
(HCSG) trades at 21. 2x forward P/E versus 24. 3x for The Coca-Cola Company — 3. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INFU: 59. 2% to $15. 00.
08Which pays a better dividend — FORA or INFU or BRT or HCSG or KO?
In this comparison, BRT (7.
0% yield), KO (2. 6% yield) pay a dividend. FORA, INFU, HCSG do not pay a meaningful dividend and should not be held primarily for income.
09Is FORA or INFU or BRT or HCSG or KO better for a retirement portfolio?
For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
23), 2. 6% yield, +115. 0% 10Y return). Both have compounded well over 10 years (KO: +115. 0%, HCSG: -29. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FORA and INFU and BRT and HCSG and KO?
These companies operate in different sectors (FORA (Healthcare) and INFU (Healthcare) and BRT (Real Estate) and HCSG (Healthcare) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FORA is a small-cap high-growth stock; INFU is a small-cap quality compounder stock; BRT is a small-cap income-oriented stock; HCSG is a small-cap quality compounder stock; KO is a large-cap quality compounder stock. BRT, KO pay a dividend while FORA, INFU, HCSG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.